/
COYA
$6.07+$0.57 (+10.36%)live
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
1
institution
Market cap
$129.0M
23M shares
52-week range
$3.71 – $7.75
58% from low
Sector
PHARMACEUTICAL PREPARATIONS
Exchange
NASDAQ
CS
Price (6 mo)
Loading chart…
Change+$1.50
Coya Therapeutics, Inc. Common Stock
Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary new therapies to enhance the function of regulatory T cells (Tregs). The company's initial development programs are focused on neurodegenerative, chronic inflammatory, autoimmune, and metabolic diseases with high unmet medical needs.
www.coyatherapeutics.com- Employees
- 8
- IPO / List date
- Dec 29, 2022
- HQ
- HOUSTON, TX
Held by traders on TradeandTell
No one on the platform currently holds COYA.
Super investors & insiders
Institutions holding (13F)
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2026-03-31 | 103,964 | $409.6K |
Insider activity (SEC Form 4)
Recent trades on TradeandTell
No one on the platform has traded COYA yet.
